Last reviewed · How we verify
MRNA-1273.222 Vaccine — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
MRNA-1273.222 Vaccine (MRNA-1273.222 Vaccine) — Sheba Medical Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| MRNA-1273.222 Vaccine TARGET | MRNA-1273.222 Vaccine | Sheba Medical Center | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- MRNA-1273.222 Vaccine CI watch — RSS
- MRNA-1273.222 Vaccine CI watch — Atom
- MRNA-1273.222 Vaccine CI watch — JSON
- MRNA-1273.222 Vaccine alone — RSS
Cite this brief
Drug Landscape (2026). MRNA-1273.222 Vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/mrna-1273-222-vaccine. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab